Holen Sie sich die Stockscreener-App
0.8768
0.25%
-0.0022
Handel nachbörslich:
.88
0.0032
+0.36%
AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten
AEON Biopharma Inc. (AEON) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
AEON Biopharma Releases New Investor Presentation - TipRanks
AEON Biopharma stock earns buy rating, holds price target on FDA meeting - Investing.com
AEON Biopharma maps FDA path for Botox biosimilar - Investing.com
AEON receives positive outcome in FDA biosimilar advisory meeting - MSN
AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting - The Manila Times
AEON Biopharma (AMEX:AEON) Stock Quotes, Forecast and News Summary - Benzinga
AEON Biopharma, Inc. (AEON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
Trading Day Triumph: AEON Biopharma Inc. (AEON) Ends at 0.83, a -12.12 Surge/Plunge - The Dwinnex
AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024 - ForexTV.com
HC Wainwright Analysts Raise Earnings Estimates for AEON Biopharma, Inc. (NASDAQ:AEON) - Defense World
Vanguard Group Inc. Increases Position in AEON Biopharma, Inc. (NASDAQ:AEON) - Defense World
AEON Biopharma (NASDAQ:AEON) Given New $5.00 Price Target at HC Wainwright - Defense World
HC Wainwright Weighs in on AEON Biopharma, Inc.’s FY2028 Earnings (NASDAQ:AEON) - Defense World
H.C. Wainwright sees potential in AEON Biopharma stock despite funding uncertainties - Investing.com Canada
Midday Stock Roundup: Veritone Soars on NCAA Deal - Orange County Business Journal
AEON Stock Earnings: AEON Biopharma Beats EPS for Q2 2024 - InvestorPlace
AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online
AEON Biopharma : Corporate Presentation - Marketscreener.com
AEON Biopharma Inc. (AEON) Stock: From Low to High in 52 Weeks - The InvestChronicle
AEON Biopharma Releases New Corporate Presentation - TipRanks
Ratio Analysis: Unpacking AEON Biopharma Inc. (AEON)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
AEON Biopharma (NASDAQ:AEON) Shares Down 11.8% - MarketBeat
Was there any good news for AEON Biopharma Inc. (AEON) stock in the last session? - US Post News
AEON Biopharma (NASDAQ:AEON) Trading Down 11.8% - Defense World
The Psychology of AEON Biopharma Inc. Inc. (AEON) Price Performance: Understanding Market Sentiment - The InvestChronicle
Insider’s View: Deciphering AEON Biopharma Inc. (AEON)’s Financial Health Through Ratios - The Dwinnex
Midday Stock Roundup: loanDepot Rises on Investor Hopes for Fed - Orange County Business Journal
Views of Wall Street’s Leading Experts on AEON Biopharma Inc. - SETE News
How to interpret AEON Biopharma Inc. (AEON)’s stock chart patterns - US Post News
AEON Biopharma Inc. (AEON) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
AEON Biopharma Inc.’s Market Journey: Closing Weak at 2.64, Down -7.69 - The Dwinnex
3 Penny Stocks to Watch Now, 7/18/24 - TipRanks
A significant driver of top-line growth: AEON Biopharma Inc. (AEON) - SETE News
Wall Street-Heavily Traded - WDRB
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
AEON’s Financial Health: Exploring AEON Biopharma Inc.’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle
Head to Head Contrast: AEON Biopharma (NASDAQ:AEON) vs. Phibro Animal Health (NASDAQ:PAHC) - Defense World
AEON Biopharma announces strategic reprioritization for ABP-450 - MSN
2.02%
0.47%
Kapitalisierung:
|
Volumen (24h):